Mersana Therapeutics EPS Basic from Accounting Change (Quarterly) Insights

Mersana Therapeutics, Inc. (MRSN)

28.73 -0.34 (-1.19%) USD | NASDAQ | Dec 29, 16:00

28.72 -0.01 (-0.03%) Pre-Market: 20:00

View EPS Basic from Accounting Change (Quarterly) for MRSN.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Basic from Accounting Change (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EPS Basic from Accounting Change (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Basic from Accounting Change (Quarterly) Benchmarks

Start Trial

Cidara Therapeutics, Inc.	--
Day One Biopharmaceuticals, Inc.	--
Semler Scientific, Inc.	--
Cue Biopharma, Inc.	--
Scholar Rock Holding Corp.	--